Elsevier licenses 13 JAMA Network journals to feed its ClinicalKey AI tool

Elsevier said on 7 October 2026 that it has signed a content agreement with the JAMA Network, putting the full text and visuals of 13 JAMA journals behind the answers given by ClinicalKey AI, its clinical AI tool for health systems ¹. The content is available to existing ClinicalKey AI customers now ¹. Neither company disclosed financial terms.

What the agreement covers

The licence takes in everything published in JAMA and JAMA Network Open, plus 11 specialty titles including JAMA Cardiology, JAMA Oncology, JAMA Internal Medicine, JAMA Psychiatry and JAMA Surgery ¹. Elsevier says the addition means ClinicalKey AI now gives clinicians full-text access to more than half of the world's top 100 medical journals ¹. Each answer the tool returns is tied to peer-reviewed sources and links through to the full article ¹.

Omry Bigger, who runs Elsevier's clinical solutions business, said that "trust is the deciding factor in whether they will use AI at the point of care", referring to what clinicians tell the company ¹. Brian Shields, publisher of the JAMA Network, said the arrangement keeps "the full article always a click away" so that clinicians can check a study's methods behind any answer ¹.

The JAMA deal is the second step this year in building out ClinicalKey AI. In June 2026 Elsevier bought Wellsheet, a US company whose software pulls together patient data from electronic health records, and which was deployed across 139 hospital sites in the US at the time ². The October announcement says deeper integration into hospital record systems, built on Wellsheet, is still to come ¹. At the time of the acquisition Elsevier said ClinicalKey AI drew on more than 1,000 medical journals and organisations and was in use in more than 300 hospitals worldwide ².

What it means for the market

For buyers in health systems, the agreement points to content as the main way clinical AI vendors now compete. Elsevier is selling its tool on the strength of the journals it can cite rather than on the model underneath, and it lists API-based integration, HIPAA-compliant use in North America, a deep research assistant and multi-language support as the enterprise features that go with it ¹. Elsevier cited a 2026 McKinsey study in which more than half of US healthcare leaders surveyed said difficulty fitting generative AI into existing workflows was the biggest barrier to scaling it, which is the gap the Wellsheet purchase is meant to close ².

For the JAMA Network, the agreement extends the reach of its research to clinicians at the moment of a decision, in Shields's account of it ¹. The release does not say whether the licence is exclusive, so rival AI vendors cannot tell from it whether the same journals remain open to them ¹.

The sources give no price, contract length or customer numbers tied to the JAMA content. The HIPAA controls Elsevier describes apply to North America, and the releases do not say how the product is offered to NHS or European buyers ¹. The integration with hospital record systems built on Wellsheet is listed as coming soon, with no date given ¹.